Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Department of CBRN Protection, TNO Defence, Safety and Security, Rijswijk, The Netherlands.
Arch Toxicol. 2019 Feb;93(2):435-451. doi: 10.1007/s00204-018-2353-2. Epub 2018 Nov 20.
Oxidative stress leads to the activation of the Nuclear factor-erythroid-2-related factor 2 (Nrf2) pathway. While most studies have focused on the activation of the Nrf2 pathway after single chemical treatment, little is known about the dynamic regulation of the Nrf2 pathway in the context of repeated exposure scenarios. Here we employed single cell live imaging to quantitatively monitor the dynamics of the Nrf2 pathway during repeated exposure, making advantage of two HepG2 fluorescent protein reporter cell lines, expressing GFP tagged Nrf2 or sulfiredoxin 1 (Srxn1), a direct downstream target of Nrf2. High throughput live confocal imaging was used to measure the temporal dynamics of these two components of the Nrf2 pathway after repeated exposure to an extensive concentration range of diethyl maleate (DEM) and tert-butylhydroquinone (tBHQ). Single treatment with DEM or tBHQ induced Nrf2 and Srxn1 over time in a concentration-dependent manner. The Nrf2 response to a second treatment was lower than the response to the first exposure with the same concentration, indicating that the response is adaptive. Moreover, a limited fraction of individual cells committed themselves into the Nrf2 response during the second treatment. Despite the suppression of the Nrf2 pathway, the second treatment resulted in a three-fold higher Srxn1-GFP response compared to the first treatment, with all cells participating in the response. While after the first treatment Srxn1-GFP response was linearly related to Nrf2-GFP nuclear translocation, such a linear relationship was less clear for the second exposure. siRNA-mediated knockdown demonstrated that the second response is dependent on the activity of Nrf2. Several other, clinically relevant, compounds (i.e., sulphorophane, nitrofurantoin and CDDO-Me) also enhanced the induction of Srxn1-GFP upon two consecutive repeated exposure. Together the data indicate that adaptation towards pro-oxidants lowers the Nrf2 activation capacity, but simultaneously primes cells for the enhancement of an antioxidant response which depends on factors other than just Nrf2. These data provide further insight in the overall dynamics of stress pathway activation after repeated exposure and underscore the complexity of responses that may govern repeated dose toxicity.
氧化应激会导致核因子-红细胞 2 相关因子 2(Nrf2)途径的激活。虽然大多数研究都集中在单一化学处理后 Nrf2 途径的激活上,但对于重复暴露情况下 Nrf2 途径的动态调节知之甚少。在这里,我们利用单细胞活细胞成像技术,利用两种 HepG2 荧光蛋白报告细胞系,分别表达 GFP 标记的 Nrf2 或硫氧还蛋白 1(Srxn1),即 Nrf2 的直接下游靶点,来定量监测重复暴露过程中 Nrf2 途径的动态变化。高通量活细胞共聚焦成像用于测量这两种 Nrf2 途径成分在反复暴露于广泛浓度范围的马来酸二乙酯(DEM)和叔丁基对苯二酚(tBHQ)后的时间动态。单一处理 DEM 或 tBHQ 会随时间推移以浓度依赖性方式诱导 Nrf2 和 Srxn1。第二次处理的 Nrf2 反应低于相同浓度的第一次暴露反应,表明反应具有适应性。此外,在第二次处理过程中,只有一小部分细胞会对 Nrf2 做出反应。尽管 Nrf2 途径受到抑制,但第二次处理导致 Srxn1-GFP 反应比第一次处理高 3 倍,所有细胞都参与了反应。第一次处理后,Srxn1-GFP 反应与 Nrf2-GFP 核易位呈线性关系,但第二次暴露时这种线性关系不太明显。siRNA 介导的敲低表明第二次反应依赖于 Nrf2 的活性。其他几种临床相关化合物(即硫氧还蛋白、呋喃妥因和 CDDO-Me)也增强了两次连续重复暴露后 Srxn1-GFP 的诱导。数据表明,对氧化剂的适应性降低了 Nrf2 的激活能力,但同时使细胞为增强抗氧化反应做好准备,而这种反应依赖于不仅仅是 Nrf2 的因素。这些数据进一步深入了解了重复暴露后应激途径激活的整体动态,并强调了可能控制重复剂量毒性的反应的复杂性。